03/5/20Categories: College Update, Faculty Pride, Research Pride
There were a lot of accomplishments from January to mid-March in the Department of Pharmaceutical Sciences! The notable list includes:
Erin Reed-Geaghan, Ph.D.
- Reed-Geaghan EG, Croxford AL, Becher B, Landreth GE. Plaque-associated myeloid cells derive from resident microglia in an Alzheimer’s disease model. J Exp Med (2020) 217 (4): e20191374.
Sheila Fleming, Ph.D.
- Neal ML, Fleming SM, Budge KM, Boyle AM, Kim C, Alam G, Beier EE, Wu LJ, Richardson JR (2020). Pharmacological inhibition of CSF1R by GW4680 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration. FASEB Journal, 34(1):1679-1694.
- Singhal NK, Sternbach S, Fleming S, Alkhayer K, Shelestack J, Popescu D, Clements R, Bottiglieri T, Freeman EJ, McDonough J (2020). Betaine restores epigenetic control and supports neuronal mitochondria in the cuprizone mouose model of multiple sclerosis. Epigenetics, in press.
Takhar Kasumov, Ph.D.
- Dr. Kasumov’s lab recently received a Micro Mouse Phenotyping Center (MMPC) award ($75,000/year). The original funding comes from NIH.
- Dr. Kasumov presented at the North American Protein Degradation Congress in San Diego on February 6, 2020. Click here for more information.
Featured in “The Pulse”
- The Office of Research and Sponsored Programs (ORSP) has received an award notice from Augusta University for a new award with funding in the amount of $75,000 to support your project titled “Mitochondrial Acetylome Dynamics in NAFLD Assessed with Heavy Water-based Metabolic Labeling” for the project period January 1, 2020 to December 31, 2020. Original source of funds is the National Institutes of Health.
- The Office of Research and Sponsored Programs has received an award agreement from Case Western Reserve University for funding in the amount of $4,080 to support the project titled “Turnover rates of mouse eyes proteins.”